Kite Pharma is a company developing cancer immunotherapy products based on cell therapy. It provides Yescarta and Tecartus, which are chimeric antigen receptor T (CAR T) cell therapies that target specific antigens in cancer cells. The company also offers the Kite External Research Program, which provides support in areas that advance medical and scientific knowledge in cell therapy.